Newsbenzinga
BMO Capital Downgrades Amgen to Market Perform, Maintains Price Target to $450
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…